TipRanks
Boston Scientific (CH:BSX)
:BSX
Switzerland Market

Boston Scientific (BSX) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

BSX Analyst Ratings

Strong Buy
21Ratings
Strong Buy
18 Buy
3 Hold
0 Sell
Based on 21 analysts giving stock ratings to
Boston
Scientific
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BSX Stock 12 Month Forecast

Average Price Target

―
Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is CHF48.35 with a high forecast of CHF57.77 and a low forecast of CHF39.62. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF57.77Average Price TargetCHF48.35Lowest Price TargetCHF39.62
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:BSX
Wells Fargo
Wells Fargo
CHF41.27→CHF39.62
Hold
―
Assigned
09/24/26
Boston Scientific price target lowered to $48 from $50 at Wells FargoBoston Scientific price target lowered to $48 from $50 at Wells Fargo
Oppenheimer Analyst forecast on CH:BSX
Oppenheimer
Oppenheimer
CHF70.15→CHF53.65
Buy
―
Assigned
09/21/26
Boston Scientific price target lowered to $65 from $85 at OppenheimerBoston Scientific price target lowered to $65 from $85 at Oppenheimer
Bank of America Securities Analyst forecast on CH:BSX
Bank of America Securities
Bank of America Securities
CHF44.57
Buy
―
Reiterated
09/20/26
Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR), Argenx Se (NASDAQ: ARGX) and Boston Scientific (NYSE: BSX)
Citi
CHF47.04→CHF41.27
Hold
―
Downgraded
09/18/26
Boston Scientific downgraded to Neutral from Buy at CitiBoston Scientific downgraded to Neutral from Buy at Citi
TD Cowen
CHF46.22
Buy
―
Reiterated
09/17/26
Analyst Maintains Buy on Boston Scientific, Viewing Cyberattack Impact as Short-Lived Despite Trimmed Near-Term Forecasts
Jefferies
CHF49.52
Buy
―
Reiterated
09/11/26
Jefferies Sticks to Its Buy Rating for Boston Scientific (BSX)
Truist Financial Analyst forecast on CH:BSX
Truist Financial
Truist Financial
―
Buy
―
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: BridgeBio Oncology Therapeutics (NASDAQ: BBOT), Pharvaris (NASDAQ: PHVS) and Boston Scientific (NYSE: BSX)
BTIG
CHF49.52→CHF46.22
Buy
―
Assigned
09/09/26
Boston Scientific price target lowered to $56 from $60 at BTIGBoston Scientific price target lowered to $56 from $60 at BTIG
Mizuho Securities Analyst forecast on CH:BSX
Mizuho Securities
Mizuho Securities
CHF57.77→CHF49.52
Buy
―
Reiterated
07/31/26
Mizuho Securities Remains a Buy on Boston Scientific (BSX)
Argus Research Analyst forecast on CH:BSX
Argus Research
Argus Research
―
Hold
―
Downgraded
07/30/26
Boston Scientific downgraded to Hold from Buy at ArgusBoston Scientific downgraded to Hold from Buy at Argus
Deutsche Bank  Analyst forecast on CH:BSX
Deutsche Bank
Deutsche Bank
CHF61.9→CHF49.52
Buy
―
Reiterated
07/30/26
Deutsche Bank Remains a Buy on Boston Scientific (BSX)
Leerink Partners Analyst forecast on CH:BSX
Leerink Partners
Leerink Partners
CHF61.07→CHF49.52
Buy
―
Reiterated
07/30/26
Boston Scientific price target lowered to $60 from $74 at LeerinkBoston Scientific price target lowered to $60 from $74 at Leerink
J.P. Morgan Analyst forecast on CH:BSX
J.P. Morgan
J.P. Morgan
CHF66.03→CHF46.22
Buy
―
Assigned
07/30/26
Boston Scientific price target lowered to $56 from $80 at JPMorganBoston Scientific price target lowered to $56 from $80 at JPMorgan
Evercore ISI Analyst forecast on CH:BSX
Evercore ISI
Evercore ISI
CHF53.65→CHF45.39
Buy
―
Reiterated
07/30/26
Boston Scientific price target lowered to $55 from $65 at Evercore ISIBoston Scientific price target lowered to $55 from $65 at Evercore ISI
Canaccord Genuity Analyst forecast on CH:BSX
Canaccord Genuity
Canaccord Genuity
CHF57.77→CHF54.47
Buy
―
Reiterated
07/30/26
Boston Scientific price target lowered to $66 from $70 at CanaccordBoston Scientific price target lowered to $66 from $70 at Canaccord
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:BSX
Wells Fargo
Wells Fargo
CHF41.27→CHF39.62
Hold
―
Assigned
09/24/26
Boston Scientific price target lowered to $48 from $50 at Wells FargoBoston Scientific price target lowered to $48 from $50 at Wells Fargo
Oppenheimer Analyst forecast on CH:BSX
Oppenheimer
Oppenheimer
CHF70.15→CHF53.65
Buy
―
Assigned
09/21/26
Boston Scientific price target lowered to $65 from $85 at OppenheimerBoston Scientific price target lowered to $65 from $85 at Oppenheimer
Bank of America Securities Analyst forecast on CH:BSX
Bank of America Securities
Bank of America Securities
CHF44.57
Buy
―
Reiterated
09/20/26
Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR), Argenx Se (NASDAQ: ARGX) and Boston Scientific (NYSE: BSX)
Citi
CHF47.04→CHF41.27
Hold
―
Downgraded
09/18/26
Boston Scientific downgraded to Neutral from Buy at CitiBoston Scientific downgraded to Neutral from Buy at Citi
TD Cowen
CHF46.22
Buy
―
Reiterated
09/17/26
Analyst Maintains Buy on Boston Scientific, Viewing Cyberattack Impact as Short-Lived Despite Trimmed Near-Term Forecasts
Jefferies
CHF49.52
Buy
―
Reiterated
09/11/26
Jefferies Sticks to Its Buy Rating for Boston Scientific (BSX)
Truist Financial Analyst forecast on CH:BSX
Truist Financial
Truist Financial
―
Buy
―
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: BridgeBio Oncology Therapeutics (NASDAQ: BBOT), Pharvaris (NASDAQ: PHVS) and Boston Scientific (NYSE: BSX)
BTIG
CHF49.52→CHF46.22
Buy
―
Assigned
09/09/26
Boston Scientific price target lowered to $56 from $60 at BTIGBoston Scientific price target lowered to $56 from $60 at BTIG
Mizuho Securities Analyst forecast on CH:BSX
Mizuho Securities
Mizuho Securities
CHF57.77→CHF49.52
Buy
―
Reiterated
07/31/26
Mizuho Securities Remains a Buy on Boston Scientific (BSX)
Argus Research Analyst forecast on CH:BSX
Argus Research
Argus Research
―
Hold
―
Downgraded
07/30/26
Boston Scientific downgraded to Hold from Buy at ArgusBoston Scientific downgraded to Hold from Buy at Argus
Deutsche Bank  Analyst forecast on CH:BSX
Deutsche Bank
Deutsche Bank
CHF61.9→CHF49.52
Buy
―
Reiterated
07/30/26
Deutsche Bank Remains a Buy on Boston Scientific (BSX)
Leerink Partners Analyst forecast on CH:BSX
Leerink Partners
Leerink Partners
CHF61.07→CHF49.52
Buy
―
Reiterated
07/30/26
Boston Scientific price target lowered to $60 from $74 at LeerinkBoston Scientific price target lowered to $60 from $74 at Leerink
J.P. Morgan Analyst forecast on CH:BSX
J.P. Morgan
J.P. Morgan
CHF66.03→CHF46.22
Buy
―
Assigned
07/30/26
Boston Scientific price target lowered to $56 from $80 at JPMorganBoston Scientific price target lowered to $56 from $80 at JPMorgan
Evercore ISI Analyst forecast on CH:BSX
Evercore ISI
Evercore ISI
CHF53.65→CHF45.39
Buy
―
Reiterated
07/30/26
Boston Scientific price target lowered to $55 from $65 at Evercore ISIBoston Scientific price target lowered to $55 from $65 at Evercore ISI
Canaccord Genuity Analyst forecast on CH:BSX
Canaccord Genuity
Canaccord Genuity
CHF57.77→CHF54.47
Buy
―
Reiterated
07/30/26
Boston Scientific price target lowered to $66 from $70 at CanaccordBoston Scientific price target lowered to $66 from $70 at Canaccord
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
CELCCelcuity
ONCBeOne Medicines
GHGuardant Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Boston Scientific

3 Months
Jayson BedfordRaymond James
Success Rate
34/53 ratings generated profit
64%
Average Return
+3.15%
Copying Jayson Bedford's trades and holding each position for 3 Months would result in 64.15% of your transactions generating a profit, with an average return of +3.15% per trade.
1 Year
Jayson BedfordRaymond James
Success Rate
39/53 ratings generated profit
74%
Average Return
+12.13%
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 73.58% of your transactions generating a profit, with an average return of +12.13% per trade.
2 Years
Jayson BedfordRaymond James
Success Rate
41/53 ratings generated profit
77%
Average Return
+22.71%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 77.36% of your transactions generating a profit, with an average return of +22.71% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BSX Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
36
25
18
8
7
Buy
52
45
47
41
39
Hold
3
3
4
2
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
91
73
69
51
50
In the current month, BSX has received 46 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the past 3 months is 48.35.
Each month's total comprises the sum of three months' worth of ratings.

BSX Financial Forecast

BSX Earnings Forecast

Next quarter’s earnings estimate for BSX is CHF0.64 with a range of CHF0.48 to CHF0.70. The previous quarter’s EPS was CHF0.71. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.
Next quarter’s earnings estimate for BSX is CHF0.64 with a range of CHF0.48 to CHF0.70. The previous quarter’s EPS was CHF0.71. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Sales Forecast

Next quarter’s sales forecast for BSX is CHF4.27B with a range of CHF3.90B to CHF4.39B. The previous quarter’s sales results were CHF4.51B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.
Next quarter’s sales forecast for BSX is CHF4.27B with a range of CHF3.90B to CHF4.39B. The previous quarter’s sales results were CHF4.51B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Stock Forecast FAQ

What is CH:BSX’s average 12-month price target, according to analysts?
Based on analyst ratings, Boston Scientific’s 12-month average price target is 48.35.
    What is CH:BSX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:BSX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Boston Scientific a Buy, Sell or Hold?
        Boston Scientific has a consensus rating of Strong Buy, which is based on 18 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Boston Scientific’s share price target?
          The average share price target for Boston Scientific is 48.35. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF57.77 ,and the lowest forecast is CHF39.62. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Boston Scientific?
            Boston Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.
              How can I buy shares of Boston Scientific?
              To buy shares of CH:BSX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.